Results 131 to 140 of about 17,227 (165)

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial. [PDF]

Neurooncol Adv
Ozer BH, Cohen AL, Colman H, Penas-Prado M, de Groot J, Loghin ME, Pan E, Raizer JJ, Kumthekar P, Fink KL, Walbert T, Merrell RT, Groves MD, Ahluwalia MS, Wu J, Burton EC, Vera E, Mendoza T, Grajkowska E, Wall K, Reyes J, Yuan Y, Armstrong TS, Gilbert MR.   +23 more
europepmc   +1 more source

Quantitative high-throughput screening identifies small-molecule modulators of Wnt/β-catenin signaling. [PDF]

Front Pharmacol
Chen X, Yang S, Sakamuru S, Sukhawanit C, Wood S, Ooka M, Huang R, Xia M.   +7 more
europepmc   +1 more source

Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma. [PDF]

Mol Ther Oncol
Kelk J, Rozanska A, Sotiriadou E, Astley D, Hussain R, Unsworth A, Gangar A, Robinson A, Queen R, Coxhead J, Steel DH, Armstrong L, Parulekar M, Hardcastle I, Veal GJ, Lako M.   +15 more
europepmc   +1 more source

NUDT1 drives osteosarcoma progression and serves as a robust predictor of clinical outcomes. [PDF]

Cancer Cell Int
Zhang Z, Wan L, Ai K, Liu J, Tang X, Duan Z, Chen R.   +6 more
europepmc   +1 more source

SGSS05-NS3, a covalent SETD8 inhibitor that activates p53 pathway in neuroblastoma. [PDF]

J Exp Clin Cancer Res
Liu Z, Bagchi S, Yan C, Hu Y, Blum G, Ma A, Jin J, Luo M, Di Bella S, Verona F, Appella E, Giannini G, Thiele CJ, Veschi V.   +13 more
europepmc   +1 more source

Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform. [PDF]

J Cheminform
Xu S, Hu Y, Mangione W, Van Norden M, Elefteriou K, Falls Z, Samudrala R.   +6 more
europepmc   +1 more source

Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models. [PDF]

Molecules
Stasiak P, Sopel J, Płóciennik A, Lipowicz JM, Rawłuszko-Wieczorek AA, Sterzyńska K, Świerczewska M, Korbecki J, Januchowski R.   +8 more
europepmc   +1 more source

Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer. [PDF]

Sci Rep
Ahmadi M, Yoosefian M.
europepmc   +1 more source

Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes. [PDF]

NAR Cancer
Heer CD, Elia JL, Menon V, Johnson SS, Arbelaez SR, Friedman S, Lopez-Giraldez F, Sundaram RK, Herzon SB, Bindra RS, Gueble SE.   +10 more
europepmc   +1 more source